There are some molecules, including GFAP, NFs, C-terminal hydrolase, UCHL1 and S100B, that are recognized as indicators of neuronal damage and suspected to be potential biomarkers of neurodegeneration in MS. This evidence concerns the gene S100B and myeloid sarcoma.